In this study the raising and development of the immune response to Borrelia burgdorferi infection in 45 Italian patients suffering from culture-confirmed Lyme Borreliosis erythema migrans (EM) was investigated. A total of 95 serially collected serum samples were tested by using three different commercial enzyme-linked immunosorbent assays (ELISAs): recomWell Borrelia, Mikrogen, Enzygnost Borreliosis, DADE Behring, and Quick ELISA C6, Immunetics. The sensitivity of Enzygnost Borreliosis IgM (70.5%) was higher than that of recomWell Borrelia IgM (55.7%), whereas recomWell Borrelia IgG was far more sensitive (57.9%) than Enzygnost Borreliosis IgG (36.8%). Quick ELISA C6 Borrelia was 62.1% sensitive. In order to compare specificity values of the three ELISAs, we tested a panel of sera obtained from blood donors (210 samples coming from a non endemic area and 24 samples from an endemic area) and from patients suffering from some of the most common biological conditions possibly resulting in false-positive reactivity in Lyme disease serology (n=40). recomWell Borrelia IgG and recomWell Borrelia IgM were the most specific (97.1% and 98.9%, respectively), followed by Quick ELISA C6 Borrelia (96.7%). Finally, Enzygnost Borreliosis IgG and IgM achieved 90.1% and 92.3% specificity, respectively. Sera that gave discrepant results when tested by the three ELISAs were further analysed by WB.

MARANGONI A., SPARACINO M., CAVRINI F., STORNI E., MONDARDINI V., SAMBRI V., et al. (2005). COMPARATIVE EVALUATION OF THREE DIFFERENT ELISA METHODS FOR THE DIAGNOSIS OF EARLY CULTURE-CONFIRMED LYME DISEASE IN ITALY. JOURNAL OF MEDICAL MICROBIOLOGY, 54, 361-367 [10.1099/jmm.0.45853-0].

COMPARATIVE EVALUATION OF THREE DIFFERENT ELISA METHODS FOR THE DIAGNOSIS OF EARLY CULTURE-CONFIRMED LYME DISEASE IN ITALY

MARANGONI, ANTONELLA;CAVRINI, FRANCESCA;STORNI, ELISA;SAMBRI, VITTORIO;CEVENINI, ROBERTO
2005

Abstract

In this study the raising and development of the immune response to Borrelia burgdorferi infection in 45 Italian patients suffering from culture-confirmed Lyme Borreliosis erythema migrans (EM) was investigated. A total of 95 serially collected serum samples were tested by using three different commercial enzyme-linked immunosorbent assays (ELISAs): recomWell Borrelia, Mikrogen, Enzygnost Borreliosis, DADE Behring, and Quick ELISA C6, Immunetics. The sensitivity of Enzygnost Borreliosis IgM (70.5%) was higher than that of recomWell Borrelia IgM (55.7%), whereas recomWell Borrelia IgG was far more sensitive (57.9%) than Enzygnost Borreliosis IgG (36.8%). Quick ELISA C6 Borrelia was 62.1% sensitive. In order to compare specificity values of the three ELISAs, we tested a panel of sera obtained from blood donors (210 samples coming from a non endemic area and 24 samples from an endemic area) and from patients suffering from some of the most common biological conditions possibly resulting in false-positive reactivity in Lyme disease serology (n=40). recomWell Borrelia IgG and recomWell Borrelia IgM were the most specific (97.1% and 98.9%, respectively), followed by Quick ELISA C6 Borrelia (96.7%). Finally, Enzygnost Borreliosis IgG and IgM achieved 90.1% and 92.3% specificity, respectively. Sera that gave discrepant results when tested by the three ELISAs were further analysed by WB.
2005
MARANGONI A., SPARACINO M., CAVRINI F., STORNI E., MONDARDINI V., SAMBRI V., et al. (2005). COMPARATIVE EVALUATION OF THREE DIFFERENT ELISA METHODS FOR THE DIAGNOSIS OF EARLY CULTURE-CONFIRMED LYME DISEASE IN ITALY. JOURNAL OF MEDICAL MICROBIOLOGY, 54, 361-367 [10.1099/jmm.0.45853-0].
MARANGONI A.; SPARACINO M.; CAVRINI F.; STORNI E.; MONDARDINI V.; SAMBRI V.; CEVENINI R.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/2514
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact